Whole-genome microarray gene expression profiling has rapidly become the gold standard platform for retrospective prognostic and predictive gene discovery in human cancers, but currently depends on ...

Agilent Technologies Inc. has introduced the Agilent SurePrint G3 Human Gene-Expression v2 Microarray, the only product available with an array of probes designed using the Broad Institute’s recently ...

The Microarray Innovations in Leukemia study assessed the clinical utility of gene expression profiling as a single test to subtype leukemias into conventional categories of myeloid and lymphoid ...

Twelve independent samples can be analyzed simultaneously on a single slide. With 135,000 long oligonucleotide probes per array, complete transcriptome coverage is achieved. Similar to the 385K and ...

Current staging methods are inadequate for predicting the outcome of treatment of non–small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely associated with survival of ...

Statistical and Biological Review of Transcriptome Data Made Possible by Interactive Report Although bench scientists understand the value of using gene-expression microarray technology, the full ...